This page is part of the FHIR Specification (v3.5.0: R4 Ballot #2). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions 
| Patient Care Work Group | Maturity Level: N/A | Ballot Status: Informative |
Raw JSON (canonical form + also see JSON Format Specification)
Definition for Code System AllergyIntoleranceClinicalStatus
{
"resourceType" : "CodeSystem",
"id" : "allergy-clinical-status",
"meta" : {
"lastUpdated" : "2018-08-19T21:48:56.559+10:00"
},
"text" : {
"status" : "generated",
"div" : "<div>!-- Snipped for Brevity --></div>"
},
"extension" : [{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
"valueCode" : "pc"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
"valueString" : "Trial Use"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
"valueInteger" : 3
}],
"url" : "http://hl7.org/fhir/allergy-clinical-status",
"identifier" : [{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.4.642.1.128"
}],
"version" : "3.5.0",
"name" : "AllergyIntoleranceClinicalStatus",
"title" : "AllergyIntoleranceClinicalStatus",
"status" : "draft",
"experimental" : false,
"date" : "2018-08-19T21:48:56+10:00",
"publisher" : "HL7 (FHIR Project)",
"contact" : [{
"telecom" : [{
"system" : "url",
"value" : "http://hl7.org/fhir"
},
{
"system" : "email",
"value" : "fhir@lists.hl7.org"
}]
}],
"description" : "The clinical status of the allergy or intolerance.",
"caseSensitive" : true,
"valueSet" : "http://hl7.org/fhir/ValueSet/allergy-clinical-status",
"content" : "complete",
"concept" : [{
"code" : "active",
"display" : "Active",
"definition" : "An active record of a risk of a reaction to the identified substance."
},
{
"code" : "inactive",
"display" : "Inactive",
"definition" : "An inactivated record of a risk of a reaction to the identified substance.",
"concept" : [{
"code" : "resolved",
"display" : "Resolved",
"definition" : "A reaction to the identified substance has been clinically reassessed by testing or re-exposure and considered to be resolved. Re-exposure could be accidental, unplanned, or outside of any clinical setting."
}]
}]
}
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.